Gastroprotective peptide trefoil factor family 2 gene is activated by upstream stimulating factor but not by c-Myc in gastrointestinal cancer cells

Gut

Volumn 51, Issue 5, 2002, Pages 685-690

  Al azzeh, E ^a   Dittrich, O ^b   Vervoorts, J ^b   Blin, N ^a   Gott P ^a   Luscher B ^b,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MAD1; PROTEIN MAD2; PROTEIN TFF1; PROTEIN TFF2; PROTEIN TFF3; TRANSCRIPTION FACTOR; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CELL; CANCER INHIBITION; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DNA BINDING; E BOX ELEMENT; GENE ACTIVATION; GENE EXPRESSION REGULATION; HEALING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MULTIGENE FAMILY; ONCOGENE C MYC; ONCOGENE MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BINDING SITES; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HUMANS; MUCINS; MUSCLE PROTEINS; NEUROPEPTIDES; PEPTIDES; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; UPSTREAM STIMULATORY FACTORS;

EID: 0036839089     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.5.685     Document Type: Article

References (38)

1. Thim L. Trefoil peptides: From structure to function. Cell Mol Life Sci 1997;53:888-903.
2. Tran CP, Cook GA, Yeomans ND, et al. Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis. Gut 1999;44:636-42.
3. Uchino H, Kataoka H, Itoh H, et al. Overexpression of intestinal trefoil factor in human colon carcinoma cells reduces cellular growth in vitro and in vivo. Gastroenterology 2000;118:60-9.
4. Wong WM, Poulsom R, Wright NA. Trefoil peptides. Gut 1999;44:890-5.
5. Playford RJ, Marchbank T, Chinery R et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995;108:108-16.
6. Lefebvre O, Chenard MP, Masson R et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996;274:259-62.
7. Mashimo H, Wu DC, Podolsky DK et al. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996;274:262-5.
8. Farrell JJ, Taupin D, Koh TJ et al. TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J Clin Invest 2002;109:193-204.
9. Gött P, Beck S, Machado JC, et al. Human trefoil peptides: Genomic structure in 21q22.3 and coordinated expression. Eur J Hum Genet 1996;4:308-15.
10. Nogueira AMMF, Machado JC, Carneiro F, et al. Patterns of expression of trefoil peptides and mucins in gastric polyps with and without malignant transformation. J Pathol 1999;187:541-8.
11. Park WS, Oh RR, Park JY, et al. Mapping of a new target region of allelic loss at 21q22 in primary gastric cancers. Cancer Lett 2000;159:15-21.
12. Beck S, Sommer P, Dos Santos Silva E, et al. Hepatocyte nuclear factor 3 (winged helix domain) activates trefoil factor gene TFF1 through a binding motif adjacent to the TATAA box. DNA Cell Biol 1999;18:157-64.
13. Al-azzeh E, Fegert P, Blin N, et al. Transcription factor GATA-6 activates expression of gastroprotective trefoil genes TFF1 and TFF2. Biochim Biophys Acta 2000;1490:324-32.
14. Zaret K. Developmental competence of the gut endoderm: Genetic potentiation by GATA and HNF3/fork head proteins. Dev Biol 1999;209:1-10.
15. Lüscher B, Larsson LG. The basic region/helix-loop-helix/leucine zipper domain of Myc proto- oncoproteins: Function and regulation. Oncogene 1999;18:2955-66.
16. Grandori C, Cowley SM, James LP, et al. The Myc/Max/Mad Network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000;16:653-99.
17. Nesbit CE, Tersak JM, Prochownik EV. MYC oncogenes and human neoplastic disease. Oncogene 1999;18:3004-16.
18. Qyang Y, Luo X, Lu T, et al. Cell-type-dependent activity of the ubiquitous transcription factor USF in cellular proliferation and transcriptional activation. Mol Cell Biol 1999;19:1508-17.
19. Sirito M, Lin Q, Deng JM, et al. Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice. Proc Natl Acad Sci 1998;95:3758-63.
20. Luo X, Sawadogo M. Functional domains of the transcription factor USF2: Atypical nuclear localization signals and context-dependent transcriptional activation domains. Mol Cell Biol 1996;16:1367-75.
21. Ismail PM, Lu T, Sawadogo M. Loss of USF transcriptional activity in breast cancer cell lines. Oncogene 1999;18:5582-91.
22. Beck S, Sommer P, Blin N, et al. 5′-flanking motifs control cell specific expression of trefoil factor genes (TFF). Int J Mol Med 1998;2:353-61.
23. Sommer A, Bousset K, Kremmer E, et al. Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators. J Biol Chem 1998;273:6632-42.
24. Sommer A, Burkhardt H, Keyse SM, et al. Synergistic activation of the mkp-1 gene by protein kinase A signaling and USF, but not c-Myc. FEBS Lett 2000;474:146-50.
25. Desbarats L, Gaubatz S, Ellers M. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Genes Dev 1996;10:447-60.
26. Dos Santos Silva E, Ulrich M, Döring G, et al. Trefoil factor family-domain peptides in the human respiratory tract. J Pathol 2000;190:133-42.
27. Strutt H, Paro R. Mapping DNA target sites of chromatin proteins in vivo by formaldehyde crosslinking. Methods Mol Biol 1999;119:455-67.
28. Bouchard C, Dittrich O, Kiermaier A, et al. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev 2001;15:2042-7.
29. Ess KC, Whitaker TL, Cost GJ, et al. A central role for a single c-Myb binding site in a thymic locus control region. Mol Cell Biol 1995;15:5707-15.
30. Davis PL, Miron A, Andersen LM, et al. Isolation and initial characterization of the BRCA2 promoter. Oncogene 1999;18:6000-12.
31. Outram SV, Owen MJ. The helix-loop-helix containing transcription factor USF activates the promoter of the CD2 gene. J Biol Chem 1994;269:26525-30.
32. Wang D, Sul HS. Upstream stimulatory factor binding to the E-box at -65 is required for insulin regulation of the fatty acid synthase promoter. J Biol Chem 1997;272:26367-74.
33. Carrasco-Serrano C, Campos-Caro A, Viniegra S, et al. GC- and E-box motifs as regulatory elements in the proximal promoter region of the neuronal nicotinic receptor alpha7 subunit gene. J Biol Chem 1998;273:20021-8.
34. Muhlethaler-Mottet A, Di Berardino W, Otten LA, et al. Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity 1998;8:157-66.
35. Azarschab P, Al-azzeh E, Kornberger W, et al. Aspirin promotes TFF2 gene activation in human gastric cell lines. FEBS Lett 2001;488:206-10.
36. Semple JI, Newton JL, Westley BR, et al. Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice. Gut 2001;48:648-55.
37. Lüdeking A, Fegert P, Blin N, et al. Osmotic changes and ethanol modify TFF gene expression in gastrointestinal cell lines. FEBS Lett 1998;439:180-4.
38. Andrews GK. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol 2000;59:95-104.